ZOLL Medical

ZOLL Medical was founded in 1980 by cardiologist Paul Zoll, whose research into non-invasive pacing led directly to the company's first product, an external pacemaker that avoided the risks of the invasive devices used at the time. That cardiac focus has stayed the core of the business for more than four decades, even as ZOLL expanded from resuscitation into a broader set of acute and critical care technologies. The company's three main areas today are resuscitation and emergency care, covering defibrillators, automated CPR devices, and trauma kits, acute critical care, covering temperature management and ventilation, and a wider set of cardiac management therapies and monitoring products. ZOLL has been a wholly owned subsidiary of the Japanese chemicals and materials conglomerate Asahi Kasei since 2012, when Asahi Kasei bought the company for roughly 2.2 billion dollars and took it private, delisting it from Nasdaq. It now operates as part of Asahi Kasei's broader healthcare portfolio rather than as an independent public company.

Within that structure, ZOLL runs a dedicated military and government line built specifically for deployed and en route care, distinct from its civilian hospital and EMS products even when the underlying technology overlaps. The Propaq M is probably the best example. It is a rugged, military airworthy-qualified vital signs monitor that can be configured with a defibrillator, pacer, and printer, and it has been selected by both the U.S. Air Force and U.S. Army as their standard deployable vital signs monitor, meaning it travels with casualties from the point of injury through aeromedical evacuation. The Propaq MD adds integrated defibrillation and multiple display modes, including a setting readable through night vision goggles, a detail that matters more than it sounds for medics working blackout conditions during night operations. On the ventilation side, ZOLL's Z Vent is a lightweight transport ventilator, under ten pounds with roughly ten hours of battery life, built to support patients from infants through adults during transport.

Its EMV+ 731 Series ventilator was developed specifically for the U.S. military rather than adapted from a civilian design, reflecting how much military transport conditions, vibration, altitude changes, limited power, differ from a hospital hallway. None of these products are exotic technology in the sense of being unique inventions. What makes them defense-relevant is durability and portability engineering layered on top of monitoring and ventilation capability that is otherwise similar to what ZOLL sells into civilian EMS and hospital markets. That overlap is part of the company's broader strategy, letting military-grade ruggedization and certification work get amortized across a much larger civilian product base. Because ZOLL is privately held under Asahi Kasei, it does not disclose employee counts or financials the way a standalone public company would, and specifics like current headcount are not publicly available.